RWE 101 – Purpose of Real World Evidence
The purpose of real-world evidence (RWE) is to provide insights into the safety, effectiveness, and value of medical products and interventions outside of the controlled environment of clinical trials. RWE is generated by collecting data from various sources, such as electronic health records, claims data, patient-generated data, and social media.
RWE is increasingly being used by healthcare stakeholders, such as regulatory agencies, payers, providers, and patients, to make informed decisions about healthcare products and interventions. For example, regulatory agencies may use RWE to supplement the evidence from clinical trials and to evaluate the safety and effectiveness of medical products in real-world settings. Payers may use RWE to make coverage and reimbursement decisions based on the value of medical products and interventions. Providers may use RWE to inform clinical decision-making and improve patient outcomes. Patients may use RWE to make more informed decisions about their own healthcare.
Overall, RWE can provide a more complete picture of the benefits and risks of medical products and interventions in real-world settings, which can lead to better healthcare decision-making and ultimately improve patient outcomes.
Share this story...
Real World Evidence (RWE) 101 – Patient Retention
RWE 101 - Patient Retention Long-term Real-World Evidence (RWE) studies face significant challenges when it comes to patient retention, for several reasons:[1] Time Commitment: Participants in RWE studies are [...]
Real World Evidence (RWE) 101 – Patient Recruitment
RWE 101 - Patient Recruitment Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic [...]
Real World Evidence (RWE) 101 – HARPER
RWE 101 - HARPER Regulatory agencies, health technology assessors, and payers are increasingly interested in studies that make use of real-world data to inform regulatory and other policy or [...]
Real World Evidence (RWE) 101 – STaRT-RWE
RWE 101 - STaRT-RWE START-RWE (Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies) was developed to address the need for improved transparency and [...]
Real World Evidence (RWE) 101 – Protocol Design and ISPE GPP
RWE 101 - Protocol Design and ISPE GPP The International Society for Pharmacoepidemiology (ISPE) Guidelines for Good Pharmacoepidemiology Practices (GPP) are a set of best practices for the conduct [...]
Real World Evidence (RWE) 101 – Protocol Design and Scientific Best Practices
RWE 101 - Protocol Design and Scientific Best Practices Designing a robust Real-World Evidence (RWE) study is crucial for generating reliable and valid insights that are acceptable to regulators. [...]
